| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/17/2004 | CN1175878C Traditional Chinese herbal medicine for treating frostbite |
| 11/17/2004 | CN1175871C Chinese traditional medicine for treating deep ulcer and bedsore |
| 11/17/2004 | CN1175865C Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof |
| 11/17/2004 | CN1175860C Complete granule for treating hepatocirrhosis and liver ascites and its preparation |
| 11/17/2004 | CN1175859C Exterior-applied medicine for treating rhinitis and nasosinusitis |
| 11/17/2004 | CN1175858C Chinese medicinal tincture for treating burn and scald and its preparing method |
| 11/17/2004 | CN1175854C Bone-setting pain stopping paste |
| 11/17/2004 | CN1175847C Pile treating ointment |
| 11/17/2004 | CN1175836C Medicine for treating pile |
| 11/17/2004 | CN1175833C Ointment for treating prostatitis and its usage |
| 11/17/2004 | CN1175828C Medicinal composition for relieving sexual fatigue and delaying senility and preparing process thereof |
| 11/17/2004 | CN1175821C Composite vitamine and trace-element nutrient for gravida and puerpera |
| 11/17/2004 | CN1175820C Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders |
| 11/17/2004 | CN1175818C Extractive preparation containing total alkali of mulberry leaves and its preparing method |
| 11/17/2004 | CN1175817C Oral liquid of sodium fructose-biphosphate and preparing process thereof |
| 11/17/2004 | CN1175816C Compound medicinal prepn. for treating acute and chronic nasosinusitis, rhinitis and tympanitis |
| 11/17/2004 | CN1175815C 1-calcium phosphate-uracil medicine and preparation method |
| 11/17/2004 | CN1175814C Slow-releasing maclobemide tablet |
| 11/17/2004 | CN1175813C Donepezil hydrochloride dripping pills |
| 11/17/2004 | CN1175812C Slow-released indapamide capsule and its preparation process |
| 11/17/2004 | CN1175811C Slow-releasing Anixitan tablet |
| 11/17/2004 | CN1175810C Composition containing calcium ascorbate and calcium L-threonate |
| 11/17/2004 | CN1175809C Use of total bryostatin for preparing medicine for anti SARS coronavirus |
| 11/17/2004 | CN1175808C Preparing method for suspensoid of complete trans vitamin A acid |
| 11/17/2004 | CN1175807C Disulfide derivatives useful for treating allergic diseases |
| 11/17/2004 | CN1175806C Antibiotic antiinflammation preparation made from extract product of Yunnan loquat as essential component |
| 11/16/2004 | US6820011 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 11/16/2004 | US6818907 Surface plasmon enhanced illumination system |
| 11/16/2004 | US6818787 Prodrugs of GABA analogs, compositions and uses thereof |
| 11/16/2004 | US6818780 Application in medicine for treatment of disorders of immunological system |
| 11/16/2004 | US6818779 Thromboxane ligands without blood clotting side effects |
| 11/16/2004 | US6818774 2-(s)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1h-isoquinolin -2-yl)- propionamide for example; alzheimer's disease or senile dementia |
| 11/16/2004 | US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity |
| 11/16/2004 | US6818765 Benzene-sulphonamide derivatives and their uses |
| 11/16/2004 | US6818761 Comprises heteropolypolysaccharide composed of alternating straight and branched portions consisting of partially acetylated and methylated galacturonic acid residues linked to rhamnose, arabinose and galactose |
| 11/16/2004 | US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders |
| 11/16/2004 | US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin) |
| 11/16/2004 | US6818739 Somatostatins |
| 11/16/2004 | US6818672 Treating endometriosis or infertility, or improving fertility |
| 11/16/2004 | US6818671 Nimesulide containing topical pharmaceutical compositions |
| 11/16/2004 | US6818670 Active ingredient combination having insecticidal and acaricidal characteristics |
| 11/16/2004 | US6818669 Increasing cerebral bioavailability of drugs |
| 11/16/2004 | US6818667 Obtained by fermenting the microorganism eurotium echinulatum delacroix (dsm 13872); inhibitors of kdr kinase, antiangiogenic agents suitable for preventing and/or treating malignant diseases |
| 11/16/2004 | US6818665 Orally administering melatonin before sleep and dehydroepiandrosterone (dhea) and adrenocorticotropic hormone |
| 11/16/2004 | US6818664 Antitumor agent which comprises said compound or a physiologically acceptable salt thereof as an active ingredient. |
| 11/16/2004 | US6818663 As inhibitors of cyclin-dependent kinase 4 (cdk4); antiproliferative agents; for therapy of cancer, tumors |
| 11/16/2004 | US6818662 N-(3-chloro-4-morpholin-4-yl)phenyl-n'-hydroxyimidoformamidine containing sulfobutyl ether beta-cyclodextrin to increase the solubility; especially a freeze-dried injectable preparation. |
| 11/16/2004 | US6818660 Calcilytic compounds |
| 11/16/2004 | US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction. |
| 11/16/2004 | US6818656 Administering polyamine to treat diarrhea |
| 11/16/2004 | US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders |
| 11/16/2004 | US6818653 6,7-Disubstituted -5,8-quinolinedione derivatives as an antifungal agent |
| 11/16/2004 | US6818652 Heterocyclic retinoid compounds |
| 11/16/2004 | US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease |
| 11/16/2004 | US6818649 Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 11/16/2004 | US6818648 Psychological disorders; anxiolytic agents; antidepressants; eating disorders; alcoholism; drug abuse; antiinflammatory agents |
| 11/16/2004 | US6818647 Method and composition for restoring diuretic and renal function |
| 11/16/2004 | US6818646 1,2,3,4-tetrahydro-2-(5-(2-pyridinyl)-pyrimidin-2-yl)-3-(2,3 -dihydrobenzofuranyl)-9h-pyrrolo-(3,4-b)quinolin-9-one; male erectile dysfunction; sexual disorders |
| 11/16/2004 | US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 11/16/2004 | US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis |
| 11/16/2004 | US6818643 Neurotrophic bicyclic diamides |
| 11/16/2004 | US6818642 Benzylaminopyrimidines |
| 11/16/2004 | US6818639 Combination of a 5-ht2c receptor agonist and a 5-ht6 receptor antagonist, or a salt, enantiomer or prodrug form |
| 11/16/2004 | US6818638 Melvinolin derivatives |
| 11/16/2004 | US6818637 For use as antidiabetic agent |
| 11/16/2004 | US6818636 B-ring estratrienes |
| 11/16/2004 | US6818635 For therapy of bacterial infections and neoplasms, |
| 11/16/2004 | US6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 11/16/2004 | US6818633 Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate |
| 11/16/2004 | US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 11/16/2004 | US6818630 Biologically active materials |
| 11/16/2004 | US6818629 Administration of a pharmaceutical formulation comprising a hydrolysis-resistant p2y receptor agonist to stimulate the removal of pathological extraneous fluid from the subretinal and retinal spaces; dinucleoside polyphosphate compound |
| 11/16/2004 | US6818625 Method for increasing survival rate of cells in animal cell culture under hypoxia condition |
| 11/16/2004 | US6818624 Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food |
| 11/16/2004 | US6818622 Selective MMP inhibitors having reduced side-effects |
| 11/16/2004 | US6818615 Antitumor, anticancer agents; synergistic mixture |
| 11/16/2004 | US6818447 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 11/16/2004 | US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 11/16/2004 | US6818233 Dietary supplements containing natural ingredients |
| 11/16/2004 | US6818232 Oat extracts: refining, compositions and methods of use |
| 11/16/2004 | US6818229 Intermediate release nicotinic acid compositions for treating hyperlipidemia |
| 11/16/2004 | US6818226 Dermal penetration enhancers and drug delivery systems involving same |
| 11/16/2004 | US6818225 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
| 11/16/2004 | US6818221 Adjuvants and processes to induce a specific type of immune response |
| 11/16/2004 | US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity |
| 11/16/2004 | US6818208 Use of a flavonoid extract of ginkgo biloba substantially devoid of terpenes, in the dentibuccal field, and composition containing such extract |
| 11/16/2004 | US6818205 Use of fluorescent whitening agents |
| 11/16/2004 | CA2465174A1 Nasal administration of xylitol to a non-human mammal |
| 11/16/2004 | CA2247164C Oxa- and thia-diazole muscarinic receptor antagonists |
| 11/16/2004 | CA2145383C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 11/16/2004 | CA2145181C Process for preparing 1-2,-substituted-5-formylimidazoles |
| 11/16/2004 | CA2107008C Antiarrhythmic and cardioprotective substituted -1(2h)isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures |
| 11/16/2004 | CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 11/16/2004 | CA2082811C 5,10-methylene-tetrahydrofolate as a modulator of a chemotherapeutic agent |
| 11/14/2004 | CA2428703A1 Method for increasing the survival of aquatic and other animals exposed to an aquatic virus, birnavirus or other rna virus and compositions for such methods |
| 11/14/2004 | CA2428564A1 Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant |
| 11/12/2004 | WO2004100889A2 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 11/11/2004 | WO2004097200A1 Internal combustin engine control device |
| 11/11/2004 | WO2004097002A2 SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF |
| 11/11/2004 | WO2004096976A2 Spex compositions and methods of use |